NCT03076892View on ClinicalTrials.gov

Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Keratosis, Actinic
Interventions
DEVICE

Aktilite® Galderma

preparation of the lesions, Metvixia application + occlusive dressing during 3 hours + illumination: 7 to 10 minutes

DEVICE

PHOS ISTOS PDT

preparation of the lesions, Metvixia application + occlusive dressing during 30 minutes + illumination: 2.5 hours

Trial Locations (2)

45657

Klinikum Vest Gmbh, Recklinghausen

59045

CHRU, Hôpital Claude Huriez, Lille

All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Lille

OTHER

NCT03076892 - Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS | Biotech Hunter | Biotech Hunter